Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19497014 | 0.97 | TSHR (0.42) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL19999960 | 0.95 | TSHR (0.43) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL5081835 | 0.90 | ZDHHC20 (0.49) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL4170086 | 0.90 | ZDHHC20 (0.49) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL21467473 | 0.90 | KCNH2 (0.44) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL11023925 | 0.87 | ZDHHC20 (0.46) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL4173370 | 0.86 | CYP1A2 (0.48) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL20756343 | 0.85 | CYP1A2 (0.52) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 | |
| SCHEMBL10646289 | 0.81 | KCNH2 (0.47) | ZDHHC20ZDHHC2KCNH2 | |
| SCHEMBL20369039 | 0.80 | CYP1A2 (0.48) | TSHRCYP1A2MAPK1ZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023942-A1 | Method for Producing Bi-Functional Ammonium Nitriles | CLARIANT PRODUKTE (DEUTSCHALND) GMBH (DE) | 2009-01-22 | — | — | US | claimed |
| EP-1856034-A1 | METHOD FOR PRODUCING BIFUNCTIONAL AMMONIUM NITRILES | Clariant Produkte (Deutschland) GmbH (DE) | 2007-11-21 | — | — | EP | claimed |
| WO-2006092247-A1 | METHOD FOR PRODUCING BIFUNCTIONAL AMMONIUM NITRILES | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2006-09-08 | — | — | WO | claimed |
| US-4737568-A | Curable resin from bis-imide amino acid hydrazide and alkenyl phenol or ether | THE BOOTS COMPANY PLC (GB) | 1988-04-12 | — | — | US | claimed |
| EP-0212808-A2 | Curable resins | Technochemie GmbH - Verfahrenstechnik (DE) | 1987-03-04 | — | — | EP | claimed |
| US-4404167-A | AMINO NITRILE INHIBITORS | ROZENFELD IOSIF L | 1983-09-13 | — | — | US | claimed |
| US-9512333-B2 | Phosphoric acid resistant polymaleimide prepolymer compositions | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2016-12-06 | — | — | US | disclosed |
| EP-2417168-B1 | PHOSPHORIC ACID RESISTANT POLYMALEIMIDE PREPOLYMER COMPOSITIONS | HUNTSMAN ADV MAT AMERICAS INC (US) | 2014-11-26 | — | — | EP | disclosed |
| EP-2710045-A1 | HALOGEN FREE THERMOSET RESIN SYSTEM FOR LOW DIELECTRIC LOSS AT HIGH FREQUENCY APPLICATIONS | Huntsman Advanced Materials Americas LLC (US) | 2014-03-26 | — | — | EP | disclosed |
| US-20140057086-A1 | Halogen Free Thermoset Resin System for Low Dielectric Loss at High Frequency Applications | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2014-02-27 | — | — | US | disclosed |
| US-20130231021-A1 | Phosphoric Acid Resistant Polymaleimide Prepolymer Compositions | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2013-09-05 | — | — | US | disclosed |
| US-8445699-B2 | Phosphoric acid resistant polymaleimide prepolymer compositions | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2013-05-21 | — | — | US | disclosed |
| WO-2012158415-A1 | HALOGEN FREE THERMOSET RESIN SYSTEM FOR LOW DIELECTRIC LOSS AT HIGH FREQUENCY APPLICATIONS | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2012-11-22 | — | — | WO | disclosed |
| US-4131707-A | POLYMALEIMIDES | CIBA-GEIGY CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
| US-4100140-A | REACTING POLYMALEIMIDES WITH ALKENYLPHENOLS OR ALKENYLPHENOL ETHERS, POLYMERIZATION CATALYSTS | CIBA-GEIGY CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-4076697-A | FROM POLYIMIDES AND POLYCARBOXYLIC ACIDS IN THE PRESENCE OF AN AMINE | CIBA-GEIGY CORPORATION (US) | 1978-02-28 | — | — | US | disclosed |
| US-4066621-A | CURABLE MIXTURES BASED ON POLYIMIDES OF UNSATURATED DICARBOXYLIC ACIDS AND INDOLE COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-4065433-A | Process for the manufacture of polyaddition products containing imide groups | CIBA-GEIGY CORPORATION (US) | 1977-12-27 | — | — | US | disclosed |
| US-4046777-A | INTERMEDIATES FOR HEAT-RESISTANT POLYMERS | CIBA-GEIGY CORPORATION (US) | 1977-09-06 | — | — | US | disclosed |
| US-4038251-A | PROCESS FOR THE MANUFACTURE OF POLYADDITION PRODUCTS CONTAINING IMIDE GROUPS BY REACTION OF POLYMALEIMIDES WITH POLYHYDRIC PHENOLS USING AMINE CATALYST | CIBA-GEIGY CORPORATION (US) | 1977-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023942-A1 | Method for Producing Bi-Functional Ammonium Nitriles | DBF4, AADAC, NAAA | TSHR 4024/4885CYP1A2 194/4885MAPK1 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.